www.psych.uic.edu

blank-picture-frame
KEY PUBLICATIONS

Harrow, M. and Jobe, T.H., 2013. Does Long-Term Treatment of Schizophrenia With Antipsychotic Medications Facilitate Recovery? Schizophrenia Bulletin, 39(5), pp. 962-965.

Harrow, M., Jobe, TH,.Faull, R. (2012) Do all schizophrenia patients need antipsychotic treatment continuously throughout their life time? A 20-year longitudinal study. Psychological Medicine, 42(10), pp. 2145-2155

Harrow, M, Jobe, TH: (2010) How frequent is chronic multiyear delusional activity and recovery in schizophrenia: A 20-year multi-followup. Schizophrenia Bulletin, 36: 192-204.

Harrow, M, Hansford, B, G, Astrachan-Fletcher, E: (2009) Locus of Control: Relation to Schizophrenia, to recovery, and to depression and psychosis-A 15-Year Longitudinal Study. Psychiatry Research, 168: 186-192.

Jobe, TH, Harrow, M: (2010). Schizophrenia: Course, Long-Term Outcome, Recovery and Prognosis, Current Directions in Psychological Science. 19: 220-225.

Strauss, GP, Harrow, M, Grossman, LS, Rosen, C. (2010) Periods of Recovery in Deficit Syndrome Schizophrenia: A 20-Year Multi–follow-up Longitudinal Study. Schizophrenia Bulletin, 36(4): 788-799.

Harrow, M, Jobe, TH: 2007. Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: A 15-year followup study. Journal of Nervous and Mental Disease, 195: 406-414.

Harrow, M, Grossman, L, Jobe, T, Herbener, E: 2005. Do patients with schizophrenia ever show periods of recovery?: A 15-year multi-follow-up study. Schizophrenia Bulletin 31:723-734.

Harrow, M, Herbener, ES, Jobe, TH, Shanklin, A, Rattenbury, F, Kaplan, KJ: 2004. Followup of Psychotic Outpatients: Dimension of delusions and work functioning in schizophrenia. Schizophrenia Bulletin 30:147-161.

Goldberg J, Harrow, M: 2001. Risk for bipolar illness in patients initially hospitalized for unipolar major depression. American Journal of Psychiatry 158:1265-1270.

Martin Harrow, Ph.D.

Professor Emeritus

Dr. Harrow, a former chessmaster who placed in the top 7 in the U.S. Open Chess Championship three times and has two draws in two tournament chess games against Bobby Fischer, is a psychologist who is a widely-cited expert on schizophrenia and bipolar disorders. He has published over 250 scientific papers and four books on these and related areas. For 31 of the last 35 years, he has been awarded major research grants from NIMH on schizophrenia.  Currently, his research is being funded by the Foundation for Excellence in Mental Health Care. In the past, he also has been awarded research grants from the MacArthur Foundation and other funding agencies. Dr. Harrow has been on the Editorial Boards of four major professional journals. As Director of the Chicago Followup Study, he has received several national awards for his research on thought disorder, psychosis, long-term adjustment, suicide, and recovery in schizophrenia. Recently his research has focused on longitudinal studies of the long-term effects of antipsychotic medications.  His national awards include the Gralnick Award by the American Association of Suicidology, an NIMH MERIT Award, and the Zubin Award by the Society for Research in Psychopathology for lifetime contributions to the understanding of psychopathology.  He also was awarded the Distinguished Faculty Award at the University of Illinois College of Medicine in 2013.

Dr. Harrow, originally from New York City, received his B.A. from the City University of New York in 1955, his Ph.D. in Psychology from Indiana University in 1961 and later earned a Diplomate in Clinical Psychology. He was on the faculty at Yale University for over 11 years, where he obtained the rank of Associate Professor prior to coming to Chicago in 1973 to assume positions as Director of Psychology at Michael Reese Medical Center and as Professor at the University of Chicago. In 1990, Dr. Harrow switched to the Medical College of the University of Illinois at Chicago where he assumed positions as Professor and Director of Psychology in the Department of Psychiatry.

Interests:

Research on schizophrenia and mood disorders

 Projects:

Longitudinal research studying factors involved in outcome and recovery in schizophrenia.
Longitudinal research studying whether patients with schizophrenia need treatment with antipsychotic medications for a lifetime.
Research studying major psychopathology, including delusional ideation, psychosis, and thought disorder-disorganization.
Research studying mood disorders.

 

 

You are here: Home Faculty ABOUT US Directory Faculty Martin Harrow, Ph.D